News
For additional media information, contact:
Arthur J. Shannon, Vice President, Investor Relations and Communications
ajshannon@perrigo.com
269-686-1709 (direct)
269-673-9128 (fax)
Archive: 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002
2007
Perrigo Announces FDA Approval for OTC Cetirizine Hydrochloride Tablets
December 28, 2007
See Attachment
Perrigo Announces Final FDA Approval of Dexcel's OTC Omegrazole; Raises Full Year Earnings Guidance
December 10, 2007
See Attachment
Perrigo To Present at Sidoti and Company 3rd Annual Emerging Growth Conference
November 5, 2007
See Attachment
Perrigo To Present at CIBC World Markets 18th Annual Healthcare Conference
November 5, 2007
See Attachment
Perrigo Reports Record Sales and Income for Fiscal 2008 First Quarter; Increases Full Year Guidance
November 1, 2007
See Attachment
Perrigo Announces That Dexcel's Settlement with AstraZenaca Allows OTC Omeprazole Launch Following Final FDA Approval
November 1, 2007
See Attachment
Perrigo Elevates Joseph C. Papa to Chairman of the Board
October 31, 2007
See Attachment
Perrigo Company Announces Dividend Increase
October 30, 2007
See Attachment
Perrigo Will Release First Quarter Fiscal 2008 Results on November 1, 2007
October 19, 2007
See Attachment
Perrigo Confirms Filing for Generic Version of Mucinex®
September 27, 2007
See Attachment
Perrigo Presentation At Analyst Meeting Sept 18, 2007
September 18, 2007
See Attachment
Perrigo To Host Analyst Meeting on September 18, 2007
September 14, 2007
See Attachment
Perrigo Vice Chair Mori Arkin to Retire After 30 Years of Service
September 13, 2007
See Attachment
Perrigo Reports Record Sales for FY 2007 Full Year and Fourth Quarter
August 23, 2007
See Attachment
Perrigo Company Announces Quarterly Dividend
August 16, 2007
See Attachment
Perrigo Will release FY 2007 Results on August 23, 2007
August 9, 2007
See Attachment
Perrigo Company Completes Qualis Acquisition
July 11, 2007
See Attachment
Perrigo Announces Tentative FDA Approval of Dexcel's OTC Omeprazole
June 20, 2007
See Attachment
Perrigo Wins Famotidine Complete Patent Litigation
June 6, 2007
See Attachment
Perrigo Receives FDA Approval to Market Coated Fruit Nicotine Gum
May 30, 2007
See Attachment
Perrigo Reports Stong Fiscal 2007 Third Quarter Revenue Growth
May 8, 2007
See Attachment
Perrigo Announces Quarterly Dividend
May 2, 2007
See Attachment
Perrigo To Present at the Morgan Stanley Global Healthcare Unplugged Conference
May 1, 2007
See Attachment
Perrigo Will Release Third Quarter Fiscal 2007 Results on May 8, 2007
April 27, 2007
See Attachment
Perrigo Announces Organizational Changes
Mar 27, 2007
See Attachment
Perrigo's Presentation Slides at the Citigroup Conference in Las Vegas
Mar 13, 2007
See Attachment
Click Here on March 13th To Hear Perrigo Present at the Citigroup Conference in Las Vegas
Mar 13, 2007 at 10:45am (PT)
See Attachment
Perrigo To Acquire Qualis, Inc.
Mar 7, 2007
See Attachment
Perrigo To Present at the Citigroup Small & Mid-Cap Conference
Mar 6, 2007
See Attachment
Perrigo To Acquire Generic Dermatological Products from Glades Pharmaceuticals
Mar 6, 2007
See Attachment
Perrigo Announces Appointment of New Board member
Feb. 22, 2007
See Attachment
Perrigo Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
Feb. 8, 2007
See Attachment
Perrigo To Present at the Merrill Lynch Global Pharma Conference on Feb 6, 2007
Feb. 1, 2007
See Attachment
Perrigo's Second Quarter Revenue Growth Driven by New Products
Feb. 1, 2007
See Attachment
Perrigo Will Release Second Quarter Fiscal 2007 Results on Feb 1, 2007
Jan. 18, 2007
See Attachment
Perrigo to Present at the 25th Annual JPMorgan Healthcare Conference
Jan. 4, 2007
See Attachment